These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 23543219)

  • 1. Insulin-like growth factor-binding protein-7 (IGFBP7) transcript: A-to-I editing events in normal and cancerous human keratinocytes.
    Hochberg M; Gilead L; Markel G; Nemlich Y; Feiler Y; Enk CD; Denichenko P; Karni R; Ingber A
    Arch Dermatol Res; 2013 Aug; 305(6):519-28. PubMed ID: 23543219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAR2 functions as a tumor suppressor via editing IGFBP7 in esophageal squamous cell carcinoma.
    Chen YB; Liao XY; Zhang JB; Wang F; Qin HD; Zhang L; Shugart YY; Zeng YX; Jia WH
    Int J Oncol; 2017 Feb; 50(2):622-630. PubMed ID: 28035363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation spectra of epidermal p53 clones adjacent to basal cell carcinoma and squamous cell carcinoma.
    Bäckvall H; Strömberg S; Gustafsson A; Asplund A; Sivertsson A; Lundeberg J; Ponten F
    Exp Dermatol; 2004 Oct; 13(10):643-50. PubMed ID: 15447725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A-to-I RNA editing of the IGFBP7 transcript increases during aging in porcine brain tissues.
    Larsen K; Kristensen KK; Momeni J; Farajzadeh L; Bendixen C
    Biochem Biophys Res Commun; 2016 Oct; 479(3):596-601. PubMed ID: 27687550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-binding protein 7 regulates keratinocyte proliferation, differentiation and apoptosis.
    Nousbeck J; Sarig O; Avidan N; Indelman M; Bergman R; Ramon M; Enk CD; Sprecher E
    J Invest Dermatol; 2010 Feb; 130(2):378-87. PubMed ID: 19710688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UV-Induced Molecular Signaling Differences in Melanoma and Non-melanoma Skin Cancer.
    Liu-Smith F; Jia J; Zheng Y
    Adv Exp Med Biol; 2017; 996():27-40. PubMed ID: 29124688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NAV3 copy number changes and target genes in basal and squamous cell cancers.
    Maliniemi P; Carlsson E; Kaukola A; Ovaska K; Niiranen K; Saksela O; Jeskanen L; Hautaniemi S; Ranki A
    Exp Dermatol; 2011 Nov; 20(11):926-31. PubMed ID: 21995814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of RUNX3 in skin cancers.
    Lee JH; Pyon JK; Kim DW; Lee SH; Nam HS; Kang SG; Kim CH; Lee YJ; Chun JS; Cho MK
    Clin Exp Dermatol; 2011 Oct; 36(7):769-74. PubMed ID: 21623876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in basal cell carcinomas.
    Stoebner PE; Le Gallic L; Berthe ML; Boulle N; Lallemant B; Marque M; Gaspard C; Delfour C; Lavabre-Bertrand T; Martinez J; Meunier L
    Exp Dermatol; 2008 Nov; 17(11):908-15. PubMed ID: 18341568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of RPE65, a putative receptor for plasma retinol-binding protein, in nonmelanocytic skin tumours.
    Hinterhuber G; Cauza K; Dingelmaier-Hovorka R; Diem E; Horvat R; Wolff K; Foedinger D
    Br J Dermatol; 2005 Oct; 153(4):785-9. PubMed ID: 16181461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer].
    Fu XR; Zhang C; Chen CY; Zhang L; Wang LX; Wang BH; Liu XY; Zhang MZ
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):369-73. PubMed ID: 22883459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGFBP7 is a p53 target gene inactivated in human lung cancer by DNA hypermethylation.
    Chen Y; Cui T; Knösel T; Yang L; Zöller K; Petersen I
    Lung Cancer; 2011 Jul; 73(1):38-44. PubMed ID: 21095038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diminished expression of C/EBPalpha in skin carcinomas is linked to oncogenic Ras and reexpression of C/EBPalpha in carcinoma cells inhibits proliferation.
    Shim M; Powers KL; Ewing SJ; Zhu S; Smart RC
    Cancer Res; 2005 Feb; 65(3):861-7. PubMed ID: 15705884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The candidate tumor suppressor gene ZAC is involved in keratinocyte differentiation and its expression is lost in basal cell carcinomas.
    Basyuk E; Coulon V; Le Digarcher A; Coisy-Quivy M; Moles JP; Gandarillas A; Journot L
    Mol Cancer Res; 2005 Sep; 3(9):483-92. PubMed ID: 16179495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGFBP7's susceptibility to proteolysis is altered by A-to-I RNA editing of its transcript.
    Godfried Sie C; Hesler S; Maas S; Kuchka M
    FEBS Lett; 2012 Jul; 586(16):2313-7. PubMed ID: 22750143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential BMI1, TWIST1, SNAI2 mRNA expression pattern correlation with malignancy type in a spectrum of common cutaneous malignancies: basal cell carcinoma, squamous cell carcinoma, and melanoma.
    Vand-Rajabpour F; Sadeghipour N; Saee-Rad S; Fathi H; Noormohammadpour P; Yaseri M; Hesari KK; Bagherpour Z; Tabrizi M
    Clin Transl Oncol; 2017 Apr; 19(4):489-497. PubMed ID: 27718152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered expression of bcl-2 family member proteins in nonmelanoma skin cancer.
    Delehedde M; Cho SH; Sarkiss M; Brisbay S; Davies M; El-Naggar AK; McDonnell TJ
    Cancer; 1999 Apr; 85(7):1514-22. PubMed ID: 10193941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoic acid receptor isoform mRNA expression differs between BCC and SCC of the skin.
    Hartmann F; Kosmidis M; Mühleisen B; French LE; Hofbauer GF
    Arch Dermatol; 2010 Jun; 146(6):675-6. PubMed ID: 20566936
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential patterns of stromelysin-2 (MMP-10) and MT1-MMP (MMP-14) expression in epithelial skin cancers.
    Kerkelä E; Ala-aho R; Lohi J; Grénman R; M-Kähäri V; Saarialho-Kere U
    Br J Cancer; 2001 Mar; 84(5):659-69. PubMed ID: 11237387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of p53 protein in benign and malignant epidermal pathologic conditions.
    Helander SD; Peters MS; Pittelkow MR
    J Am Acad Dermatol; 1993 Nov; 29(5 Pt 1):741-8. PubMed ID: 8227547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.